Neurosyphilis: A current review

Current Infectious Disease Reports

Volumn 7, Issue 4, 2005, Pages 277-284

  O'Donnell, Judith A ^a   Emery, Christopher L ^b  

^a HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; STEROID;

CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CROSS REACTIVITY; DRUG HALF LIFE; ELECTROIMMUNOASSAY; FLUORESCENT TREPONEMA ANTIBODY TEST; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; LUMBAR PUNCTURE; MEDICAL DECISION MAKING; NEUROSYPHILIS; NONHUMAN; PATIENT CARE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; REVIEW; SUPERINFECTION; TREPONEMA PALLIDUM HEMAGGLUTINATION TEST; VENEREAL DISEASE REACTION TEST;

EID: 23844482745     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-005-0060-7     Document Type: Review

References (45)

1. Merritt HH, Adams RD, Solomon HC: Neurosyphilis. New York: Oxford University Press; 1946.
2. Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of STDs: Sexually Transmitted Diseases Surveillance 2001. Atlanta, GA. Centers for Disease Control and Prevention; 2002.
3. Whiteside CM: Persistence of neurosyphilis despite multiple treatment regimens. Am J Med 1989, 87:225-227.
4. Musher DM, Hamill RJ, Baugh RE: Effect of human immuno-deficiency virus infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990, 113:872-881.
5. Katz DA, Berger JR: Neurosyphilis in acquired immuno-deficiency syndrome. Arch Neurol 1989, 46:895-898.
6. Gordon SM, Eaton ME, George R, et al.: The response of symptomatic neurosyphilis to high dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994, 331:1469-1473.
7. Brandt AM: Shadow on the land. In No Magic Bullet: A Social History of Venereal Disease in the United States Since 1880. New York: Oxford University Press; 1987.
8. Ciesielski CA: Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep 2003, 5:145-157.
9. Sexually transmitted diseases in men who have sex with men - New York City, 2001. MMWR Morb Mortal Wkly Rep 2002, 51:853-856.
10. Transmission of primary and secondary syphilis by oral sex - Chicago, Illinois 1998-2002. MMWR Morb Mortal Wkly Rep 2004, 53:966-968.
11. Lukehart SA, Hook EW 3rd, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855-862.
12. Golden MR, Marra CM, Holmes KK: Update on syphilis: resurgence of an old problem. JAMA 2003, 290:1510-1514.
13. Tramont EC: Syphilis in adults: from Christopher Columbus to Sir Alexander Fleming to AIDS. Clin Infect Dis 1995, 21:1361-1371.
14. Tramont EC: Neurosyphilis. http://pier.acponline.org/physicians/diseases/d777/d777.html. Accessed March 23, 2005.
15. Ances BM, Shellhaus R, Brown MJ, et al.: Neurosyphilis and status epilepticus: case report and literature review. Epilepsy Res 2004, 59:67-70.
16. Jacquemin GL, Proulx P, Gilbert DA, et al.: Functional recovery from paraplegia caused by syphilitic meningomyelitis. J Spinal Cord Med 2002, 25:133-137.
17. Becker GD: Late syphilitic hearing loss: a diagnostic and therapeutic dilemma. Laryngoscope 1979, 89:1273-1288.
18. Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection: the Syphilis and HIV study group. N Engl J Med 1997, 337:307-314.
19. Rompalo AM, Joesoef MR, O'Donnell JA, et al.: Clinical manifestations of early syphilis by HIV status and gender: results of the Syphilis and HIV study. Sex Transm Dis 2001, 28:158-165.
20. Sexually Transmitted Diseases Treatment Guidelines 2002: Centers for Disease Control & Prevention. MMWR Recomm Rep 2002, 51:1-78.
21. Marra CM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369-376.
22. van der Valk PGM, Kraai EJ, van Voorst Vadev PC, et al.: Penicillin concentrations in cerobrospinal fluid during repository treatment regimen for syphilis. Genitourin Med 1988, 64:223-225.
23. Scheck DN, Hook EW 3rd: Neurosyphilis. Infect Dis Clin North Am 1994, 8:769-790.
24. Chan DJ: Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr HIV Res 2005, 3:95-98.
25. Norris SJ, Popee VP, Johnson RE, Larsen SA: Treponema and other host-associate spirochetes. In Manual of Clinical Microbiology, edn 8. Edited by Murray PR, Barron EJ, Jorgensen JH, et al. Washington, DC: ASM Press; 2003:955-971.
26. Larsen SA, Stiener BM, Rudolph AL: Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995, 8:1-21.
27. Peter JB: Treponema pallidum. In Use and Interpretation of Laboratory Tests in Infectious Diseases, edn 6. Edited by Peter JB. Santa Monica, CA: Specialty Laboratories; 2000:256-257.
28. Participant Summary. G-C Syphilis Serology Survey. Chicago, IL: College of American Pathologists; 2004:1-17.
29. Marra CM, Critchlow CW, Hook EW 3rd, et al.: Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995, 52:68-72.
30. Luger AF, Schmidt BL, Kaulich M: Significance of laboratory findings for diagnosis of neurosyphilis. Int J STD AIDS 2000, 22:224-234.
31. Grimpel EP, Sanchez PJ, Wendel GD, et al.: Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid. J Clin Microbiol 1991, 29:1711-1718.
32. Noordhoek DT, Wolters EC, De Jonge MEJ, van Embden JDA: Detection by polymerase chain reaction of Treponema pallidum DNA in cerebrospinal fluid from neurosyphilis patients before and after antibiotic therapy. J Clin Microbiol 1991, 29:1976-1984.
33. Liu H, Rodes B, Chen CY, Steiner B: New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase 1 gene. J Clin Microbiol 2001, 39:1941-1946.
34. Collier AC, Marra CM, Coombs RW, et al.: Central nervous system manifestations in HIV and AIDS. J Acquir Immune Defic Syndr 1992, 5:229-241.
35. Marshall DW, Brey RL, Cahill WT, et al.: Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988, 45:954-958.
36. Onoda Y: Therapeutic effect of oral doxycycline in syphilis. Br J Vener Dis 1979, 55:110-115.
37. Yim CW, Flynn NM, Fitzgerald PT: Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother 1985, 28:347-348.
38. Johnson RC, Bey RF, Wolgamot SJ: Comparison of the activities of ceftriaxone and penicillin against experimentally induced syphilis in rabbits. Antimicrob Agents Chemother 1982, 21:984-989.
39. Marra CM, Slatter V, Tartaglione TA, et al.: Evaluation of aqueous penicillin G and ceftriaxone for experimental neurosyphilis [letter]. J Infect Dis 1992, 165:346-347.
40. Schofer H, Vogt HJ, Milbradt R: Ceftriaxone for treatment of primary and secondary syphilis. Chemotherapy 1989, 35:440-445.
41. Dowell ME, Ross PG, Musher DM, et al.: Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992, 93:481-488.
42. Marra CM, Boutin P, MCArthur JL, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in HIV-infected individuals. Clin Infect Dis 2000, 30:540-544.
43. Smith NH, Musher DM, Huang DB, et al.: Response of HIV-infected patients with asymptomatic neurosyphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15:328-332.
44. Pao D, Gob BT, Bingham JS: Management issues in syphilis. Drugs 2002, 62:1447-1461.
45. Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004, 38:1001-1006.